These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28341067)

  • 61. Delayed manipulation after collagenase clostridium histolyticum injection for Dupuytren contracture.
    Kaplan FT; Badalamente MA; Hurst LC; Merrell GA; Pahk R
    Hand (N Y); 2015 Sep; 10(3):578-82. PubMed ID: 26330801
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
    Smeraglia F; Del Buono A; Maffulli N
    Br Med Bull; 2016 Jun; 118(1):149-58. PubMed ID: 27151958
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Early outcomes of a sequential series of 144 patients with Dupuytren's contracture treated by collagenase injection using an increased dose, multi-cord technique.
    Verheyden JR
    J Hand Surg Eur Vol; 2015 Feb; 40(2):133-40. PubMed ID: 24698852
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost-effectiveness of Recurrent Dupuytren Contracture Treatment.
    Yoon AP; Kane RL; Hutton DW; Chung KC
    JAMA Netw Open; 2020 Oct; 3(10):e2019861. PubMed ID: 33030553
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enzyme injection as nonsurgical treatment of Dupuytren's disease.
    Badalamente MA; Hurst LC
    J Hand Surg Am; 2000 Jul; 25(4):629-36. PubMed ID: 10913202
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up.
    Watt AJ; Curtin CM; Hentz VR
    J Hand Surg Am; 2010 Apr; 35(4):534-9, 539.e1. PubMed ID: 20353858
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dupuytren's Contracture Recurrence and Treatment Following Collagenase Clostridium Histolyticum Injection: A Longitudinal Assessment in a Veteran Population.
    Zarb RM; Graf AR; Talhelm JE; Stehr RC; Sanger JR; Matloub HS; Daley RA
    Mil Med; 2023 Aug; 188(9-10):e2975-e2981. PubMed ID: 36928340
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term Effects of Skin Tearing on Outcomes After Collagenase Treatment of Dupuytren Contractures.
    Zhang D; Blazar P; Benavent KA; Earp BE
    Hand (N Y); 2021 Nov; 16(6):792-796. PubMed ID: 31941375
    [No Abstract]   [Full Text] [Related]  

  • 69. [Treatment of Dupuytren's disease with collagenase - a 1-year follow-up of 37 patients].
    Binter A; Neuwirth M; Rab M
    Handchir Mikrochir Plast Chir; 2014 Dec; 46(6):355-60. PubMed ID: 25564949
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Treatment of Dupuytren's disease using collagenase from Clostridium histolyticum].
    Martín-Ferrero MÁ; Simón-Pérez C; Rodríguez-Mateos JI; García-Medrano B; Hernández-Ramajo R; Brotat-García M
    Rev Esp Cir Ortop Traumatol; 2013; 57(6):398-402. PubMed ID: 24071041
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
    Holzer LA; Holzer G
    N Engl J Med; 2009 Dec; 361(26):2579; author reply 2579-80. PubMed ID: 20050321
    [No Abstract]   [Full Text] [Related]  

  • 72. New insights into the immediate outcome of collagenase injections for Dupuytren's contracture.
    Warwick DJ; Graham D; Worsley P
    J Hand Surg Eur Vol; 2016 Jul; 41(6):583-8. PubMed ID: 26307140
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Collagenase Treatment of Dupuytren's Disease with Minimum 5-Year Follow-Up: Recurrence, Reintervention, and Satisfaction.
    Zhang D; Earp BE; Benavent KA; Blazar P
    Plast Reconstr Surg; 2020 Nov; 146(5):1071-1079. PubMed ID: 33136952
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Does collagenase injection disrupt or digest the Dupuytren's cord: a magnetic resonance imaging study.
    Crivello KM; Potter HG; Moon ES; Rancy SK; Wolfe SW
    J Hand Surg Eur Vol; 2016 Jul; 41(6):614-20. PubMed ID: 26768221
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Patient Preferences for Limited Fasciectomy Versus Collagenase Treatment for Dupuytren Contracture.
    Zhang D; Blazar P; Benavent KA; Earp BE
    J Hand Surg Asian Pac Vol; 2022 Apr; 27(2):242-247. PubMed ID: 35404200
    [No Abstract]   [Full Text] [Related]  

  • 76. Finger Joint Contractures 5 Years After Treatment for Dupuytren Disease: A Comparative Cohort Study of Collagenase Injection Versus Surgical Fasciectomy.
    Eckerdal D; Lauritzson A; Nordenskjöld J; Åkesson A; Atroshi I
    J Hand Surg Am; 2022 Sep; 47(9):834-842. PubMed ID: 35868901
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.
    Gilpin D; Coleman S; Hall S; Houston A; Karrasch J; Jones N
    J Hand Surg Am; 2010 Dec; 35(12):2027-38.e1. PubMed ID: 21134613
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability.
    Lauritzson A; Atroshi I
    BMJ Open; 2017 Mar; 7(3):e012943. PubMed ID: 28298365
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Treatment of Dupuytren's disease with collagenase Clostridium histolyticum].
    Keller M; Arora R; Schmiedle G; Kastenberger T
    Orthopade; 2017 Apr; 46(4):321-327. PubMed ID: 28138723
    [TBL] [Abstract][Full Text] [Related]  

  • 80. One year follow-up after treatment with CCH for Dupuytren's disease: A prospective view.
    Sanjuán-Cerveró R; Vazquez-Ferreiro P; Gómez-Herrero D; Carrera-Hueso FJ; Fikri-Banbrahim N
    Rev Esp Cir Ortop Traumatol (Engl Ed); 2018; 62(6):448-457. PubMed ID: 29519629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.